MXL nutritional supplement

Clinical Results

Many products claim to have clinical trials that support their use but either don't show their results, or worse, have not published them in a scientific journal. Only when clinical results have appeared in a scientific journal, which means they have been independently approved by other experts in the field, can they be considered valid. The careful consumer should watch for non-supported claims.

The researchers of MXL have published numerous articles in scientific journals that utilized the components of MXL, and led to its development. For a comprehensive list of published articles and presentations see The Science behind MXL.

Results from 3 separate clinical trials with MXL have been published in The American Journal of Alzheimer's Disease & Other Dementias and the Journal of Nutrition, Health and Aging:

Chan A, Paskavitz J, Remington R and Shea TB (2008) Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: A one-year open-label pilot study with a 16-month extension. Am J Alz Dis Other Dementias 23: 571-585

Remington R, Chan A and Shea TB (2009) Efficacy of a vitamin/nutriceutical formulation for moderate to late-stage Alzheimer's disease: A placebo-controlled pilot study. Am J Alz Dis Other Dementias 24: 27-33.

Chan A, Remington R. Kotya E, Lepore A and Shea TB. A vitamin/neutriceutical formulation improves memory and cognitive performance in community-dwelling adults with no known or suspected cognitive impairment. Journal of Nutrition, Health and Aging: in press

Note that MXL is the product name, and in the clinical trials, we refer to the components of MXL as a "vitamin/nutriceutical formulation".